Warfarine in Unexplained Oligohydramnios

• Status: Terminated
• Trial end date: 2011-07-01
• Target enrollment: 0
• Participant gender: Female

Summary

This study examines using oral anti coagulant warfarin in the management of unexplained oligohydramnios improve the perinatal outcome with little or no complications to the mother or the neonates.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Woman's Health University Hospital, Egypt
• Treatments: Anticoagulants; Coagulants; Warfarin

Criteria

Inclusion Criteria:

• Patients were eligible for inclusion if they were 28th to 32nd weeks of pregnancy and

• age 18-35 years and

• diagnosed to have idiopathic oligohydramnios excluded by medical history and

• detailed u/s examination,

• the cut off AFI was less than 5cm

Exclusion Criteria:

• Exclusion criteria were chronic hypertension,

• anaemia,

• cardiac diseases,or

• history of premature rupture of membrane or

• structural malformations.